IPO Databook: Veradermics (MANE US) - Aug 2026
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing innovative therapeutics for aesthetic and...
111 Views
Primer: VeraDermics (MANE US) - Aug 2026
VeraDermics is a late-stage clinical biopharmaceutical company shifting its focus from a broad dermatology platform, including wart treatments,...
93 Views
VeraDermics (MANE US): Synthetic Expert Call Transcript (03 Aug 2026)
Veradermics’ commercial model relies heavily on a premium out-of-pocket cash-pay framework, directly capturing demand from patients fatigued by...
120 Views
Veradermics, Inc. (MANE): Six Months Later: Hair Today, Higher Tomorrow, 2026's Breakout Story
​Article highlights exceptional IPO performance with shares doubling at opening trade and climbing over 670% from IPO price, positive Phase 3 data...
141 Views
Veradermics, Inc. (MANE): Dermatology Biotech Blasts Off, Eli Lilly and Wellington Anchor Hot IPO
​VeraDermics biotech IPO soars on first day with anchor-driven demand, but caution advised due to potential near-term volatility.
280 Views